You have executed a tag search on The Deal Pipeline. Below, you will find a comprehensive list of stories tagged "Committee For Medicinal Products for Human Use."
1 result(s) displayed (1 - 1 of 1)
The decision tied to the approval of Folotyn cannot be appealed, but rejection does not endanger the company's $200 million merger with Spectrum Pharmaceuticals. Continue reading
Posted on June 28, 2012 4:19 PM
Movable Type search results powered by Fast Search